G01N2333/91085 - CPC Classification Index

ClassID:

170614 ⎘

G01N2333/91085 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Transferases (2.); Acyltransferases (2.3); Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-) Transglutaminases; Factor XIIIq (2.3.2.13)

Recent Application in this class:

20250188509

2025-06-12

METHOD FOR DETECTING AND/OR QUANTIFYING CROSSLINKS FORMED BY TRANSGLUTAMINASES

20250147024

2025-05-08

TRANSGLUTAMINASE SUBSTRATES FOR LABELING

20240255532

2024-08-01

Biomarkers for the Detection of Thrombosis or Coagulation-Related Disorders and Their Applications

20240241134

2024-07-18

NOVEL BIOLOGICAL MARKERS IN THE DIAGNOSIS OF ENDOMETRIOSIS

20240044897

2024-02-08

METHOD OF PROGNOSIS AND/OR DIAGNOSIS OF A PELLICULAR CONDITION OF THE SCALP

20220249642

2022-08-11

Combination of Markers for Predicting the Response to Vx-001

20220146501

2022-05-12

ASSAY METHODS FOR THE DETECTION OF HUMAN SERUM ALBUMIN, VITAMIN D, C-REACTIVE PROTEIN, AND ANTI-TRANSGLUTAMINASE AUTOANTIBODY

20210405073

2021-12-30

Factor XIII immunoassay

20210341493

2021-11-04

tTG-DGP BIOMARKERS FOR MONITORING CELIAC DISEASE

#10

20200371102

2020-11-26

System and method for identification and characterization of transglutaminase species

#11

20200249231

2020-08-06

System and method for identification and characterization of transglutaminase species

#12

20190338338

2019-11-07

NOVEL USES OF CATALYTIC PROTEIN

#13

20180252714

2018-09-06

System and method for identification and characterization of transglutaminase species

#14

20180003724

2018-01-04

ALZHEIMER'S DISEASE DIAGNOSTIC PANELS AND METHODS FOR THEIR USE

#15

20180000102

2018-01-04

Method and compositions for reducing immunorecognition of dietary protein

#16

20170146531

2017-05-25

Recombinant Deamidated Gliadin Antigen

#17

20160363592

2016-12-15

Method for determining FXIII levels as a prognostic biomarker in acute myocardial infarction

#18

20160178627

2016-06-23

System and method for identification and characterization of transglutaminase species

#19

20150247870

2015-09-03

Method for aiding diagnosis of Alzheimer's disease

#20

20150198618

2015-07-16

ALZHEIMER'S DISEASE DIAGNOSTIC PANELS AND METHODS FOR THEIR USE

#21

20150126622

2015-05-07

Blood biomarkers for necrotizing enterocolitis

#22

20150004625

2015-01-01

NOVEL PROGNOSTIC BIOMARKER IN ACUTE MYOCARDIAL INFARCTION

#23

20140024837

2014-01-23

Cinnamoyl inhibitors of transglutaminase

#24

20130045493

2013-02-21

DIAGNOSIS AND TREATMENT OF GLUTEN-INDUCED AUTOIMMUNE DISEASES

#25

20120315262

2012-12-13

Stabilized open form transglutaminase as a diagnostic indictor for autoimmune diseases

#26

20120283127

2012-11-08

Diagnostic method for Alzheimer's disease

#27

20120238476

2012-09-20

ALZHEIMER'S DISEASE DIAGNOSTIC PANELS AND METHODS FOR THEIR USE

#28

20120190052

2012-07-26

Method of determining factor XIII by means of NAD(P)H-analogues

#29

20110265557

2011-11-03

Method of quality control testing a Factor XIII containing sample

#30

20110237677

2011-09-29

Inhibitors

#31

20100204280

2010-08-12

Cinnamoyl inhibitors of transglutaminase

#32

20100160348

2010-06-24

MATERIALS AND METHODS FOR DETECTING AND TREATING PERITONEAL OVARIAN TUMOR DISSEMINATION INVOLVING TISSUE TRANSGLUTAMINASE

#33

20090311727

2009-12-17

RECOMBINANT DEAMIDATED GLIADIN ANTIGEN